SE0100374D0 - Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof - Google Patents
Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereofInfo
- Publication number
- SE0100374D0 SE0100374D0 SE0100374A SE0100374A SE0100374D0 SE 0100374 D0 SE0100374 D0 SE 0100374D0 SE 0100374 A SE0100374 A SE 0100374A SE 0100374 A SE0100374 A SE 0100374A SE 0100374 D0 SE0100374 D0 SE 0100374D0
- Authority
- SE
- Sweden
- Prior art keywords
- novel compositions
- inhibitors
- protein kinase
- potassium channel
- channel openers
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0100374A SE0100374D0 (sv) | 2001-02-07 | 2001-02-07 | Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof |
EP02715944A EP1357974A1 (en) | 2001-02-07 | 2002-01-23 | Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof |
JP2002562427A JP2004518701A (ja) | 2001-02-07 | 2002-01-23 | カリウムチャネル開口薬およびプロテインキナーゼc阻害薬の新規な組成物ならびにそれらの使用 |
PCT/SE2002/000105 WO2002062422A1 (en) | 2001-02-07 | 2002-01-23 | Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof |
US10/059,658 US20020137692A1 (en) | 2001-02-07 | 2002-01-29 | Novel compositions of potassium channel openers and protein kinase C inhibitors and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0100374A SE0100374D0 (sv) | 2001-02-07 | 2001-02-07 | Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0100374D0 true SE0100374D0 (sv) | 2001-02-07 |
Family
ID=20282870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0100374A SE0100374D0 (sv) | 2001-02-07 | 2001-02-07 | Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1357974A1 (sv) |
JP (1) | JP2004518701A (sv) |
SE (1) | SE0100374D0 (sv) |
WO (1) | WO2002062422A1 (sv) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070208087A1 (en) | 2001-11-02 | 2007-09-06 | Sanders Virginia J | Compounds, compositions and methods for the treatment of inflammatory diseases |
PT1511710E (pt) | 2002-05-31 | 2014-02-26 | Proteotech Inc | Compostos, composições e métodos para o tratamento de doenças da amiloide e sinucleínopatias tais como doença de alzheimer, diabetes do tipo 2, e doença de parkinson |
JP2006507357A (ja) * | 2002-10-11 | 2006-03-02 | プロテオテック・インコーポレイテッド | プロシアニジンb2の単離、精製および合成ならびにその使用 |
EP1921076A1 (en) * | 2002-10-11 | 2008-05-14 | Proteotech Inc. | systhesis of procyanidin B2 |
HUE052571T2 (hu) * | 2008-09-27 | 2021-05-28 | Jina Pharmaceuticals Inc | Lipid alapú gyógyszerészeti készítmények helyi alkalmazáshoz |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4596812A (en) * | 1976-05-24 | 1986-06-24 | The Upjohn Company | Methods and solutions for treating male pattern alopecia |
DE69117762T2 (de) * | 1990-08-10 | 1996-08-08 | The Upjohn Company, Kalamazoo, Mich. | Stimulierung des haarwuchses mit kaliumchannelöffnern und 5-alpha-reduktase-inhibitoren |
AU686691B2 (en) * | 1994-01-12 | 1998-02-12 | F. Hoffmann-La Roche Ag | Novel azepanes and homologs thereof |
ES2199996T3 (es) * | 1994-06-30 | 2004-03-01 | Kyowa Hakko Kogyo Co., Ltd. | Producto estimulador del crecimiento de los cabellos. |
TW339325B (en) * | 1995-07-05 | 1998-09-01 | Hoffmann La Roche | Novel azepane derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
KR100499190B1 (ko) * | 1996-03-29 | 2006-04-17 | 교와 핫꼬 고교 가부시끼가이샤 | 육모제 |
-
2001
- 2001-02-07 SE SE0100374A patent/SE0100374D0/sv unknown
-
2002
- 2002-01-23 WO PCT/SE2002/000105 patent/WO2002062422A1/en not_active Application Discontinuation
- 2002-01-23 JP JP2002562427A patent/JP2004518701A/ja not_active Withdrawn
- 2002-01-23 EP EP02715944A patent/EP1357974A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2002062422A1 (en) | 2002-08-15 |
EP1357974A1 (en) | 2003-11-05 |
JP2004518701A (ja) | 2004-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20005224L (no) | BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse | |
MXPA03011342A (es) | Composicion para tinte de fibras queratinicas que comprende colorante diazoico dicationico particular. | |
CY1111599T1 (el) | Αναστολεις κινασης θειενοπυριδινης και φουροπυριδινης | |
BR0214309A (pt) | Derivados aril-1,4-pirazina substituìdos | |
MXPA03011393A (es) | Composicion para tenido de fibras queratinicas que comprende colorante diazoico dicationico particular. | |
NO20041917D0 (no) | Spesifikke midler som binder humant angiopoietin-2 | |
PT1347971E (pt) | Inibidores tiazolilicos de tirosina-cinases da familia tec | |
DE60327999D1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
YU9404A (sh) | Multimerna, usmerena kontrastna sredstva na bazi peptida | |
WO2003073999A3 (en) | Pini-modulating compounds and methods of use thereof | |
ATE494884T1 (de) | Oxidative zusammensetzung zur behandlung von keratinfasern, die spezielle aminosilikone enthält | |
BR0309665A (pt) | Tratamento de deficiência de alfa-galactosidase a | |
WO2003053383A3 (fr) | Utilisation cosmetique d’au moins une hydrophobine pour le traitement des matieres keratiniques | |
BR0215360A (pt) | Derivados de indolina úteis como inibidores de proteìna quinase | |
WO2003074550A3 (en) | Pin1-modulating compounds and methods of use thereof | |
MXPA02002118A (es) | Composiciones que contienen productos leguminosos. | |
ATE288747T1 (de) | Methoden und zusammensetzungen zur modulierung der aktivität von alpha-adrenergen rezeptoren | |
DK1097173T3 (da) | Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler | |
CY1109995T1 (el) | Συνθεσεις περιεχουσες προϊοντα σογιας | |
BR0315437A (pt) | Composição para o tratamento dos cabelos, usos da mesma e método para o tratamento dos cabelos | |
MXPA02002119A (es) | Productos leguminosos. | |
WO2005094761A8 (en) | Hair treatment compositions comprising a disaccharide, a di-acid and a source of ammonium ions | |
MXPA02002117A (es) | Uso de productos leguminosos para el tratamiento de agresiones externas. | |
DK1162956T3 (da) | Sammensætninger og fremgangsmåder til forbedring af integritet af kompromitterede legemskanaler og - kaviteter | |
DE60237003D1 (de) | Verwendung von 3-positions-cyclosporin-derivaten für haarwachstum |